BHC Bausch Health Companies Inc.

TSX · CA · Healthcare · Drug Manufacturers - Specialty & Generic · bauschhealth.com

8.270CAD+1.72%Mkt Cap: 2.25B $P/E: —3d ago

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The comp…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$64.70BUSDP/E 25.1

TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$38.70BUSDP/E 18.3

ZTS

Zoetis Inc. Class A Common Stock

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

HIK

Hikma Pharmaceuticals PLC

$4.19BUSDP/E 11.9

Key Statistics

Company

Market Cap2.25B USD

Enterprise Value16.72B USD

Revenue (TTM)7.90B USD

Gross Profit5.28B USD

Net Income (TTM)114.34M USD

Revenue/Share29.12 CAD

Last Price8.270 CAD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees20.3K

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISINCA0717341071

Valuation

P/E (Trailing)—

P/E (Forward)1.38

PEG0.02

EV/EBITDA5.88

EV/Revenue2.12

P/S0.28

P/B-1.21

EPS (TTM)-4.17

EPS (Forward)5.87

52W Range

6.10044% of range11.08

52W High11.08 CAD

52W Low6.100 CAD

Profitability

Gross Margin70.65%

Oper. Margin27.17%

EBITDA Margin36.01%

Profit Margin1.53%

ROE-28.34%

ROA0.60%

Growth

Revenue Growth12.70%

Earnings Growth70.40%

Cash Flow & Leverage

Operating CF1.02B USD

CapEx (TTM)296.40M USD

FCF Margin13.21%

FCF Yield46.35%

Net Debt13.80B USD

Net Debt/EBITDA4.85

Balance Sheet

Debt/Equity-37.64

Current Ratio1.44

Quick Ratio0.90

Book Value/Sh-6.72 CAD

Cash/Share4.88 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 CAD

Div. Yield—

5Y Avg Yield6.46%

Payout Ratio0.00%

Ex-Div DateNov 10, 2010

Pay Date—

Splits

Last Split2:1

Split DateOct 5, 2000

Analyst Consensus

Rating3.0 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.373.99M

Float260.57M

Insiders11.12%

Institutions65.02%

Short Interest

Short Ratio4.0d

Short % Float0.91%

Short % Out.0.73%

Shares Short2.73M

Short (prev mo.)3.59M

Technical

SMA 508.349 (-0.9%)

SMA 2008.002 (+3.4%)

Beta0.37

S&P 52W Chg13.94%

Avg Vol (30d)626.63K

Avg Vol (10d)565.66K

Technical Indicators

RSI (14)50.3

MACD-0.0525

MACD Signal-0.0335

MACD Hist.-0.0190

BB Upper9.280 CAD

BB Middle8.342 CAD

BB Lower7.404 CAD

BB Width22.50%

ATR (14)0.3515 CAD

Vol Ratio (20d)1.05x